Lilly to Participate in Guggenheim Oncology Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Oncology Conference on February 9, 2023. Key executives, including Jacob Van Naarden, CEO of Loxo@Lilly, and Dr. David Hyman, Chief Medical Officer, will engage in a fireside chat at 10:10 a.m. Eastern Time.
A live audio webcast of the event can be accessed through the 'Webcasts & Presentations' section on Lilly's Investor website. A replay will be available for 30 days after the event. Lilly has been at the forefront of medical innovations for nearly 150 years, focusing on life-changing therapies and ensuring accessibility for millions globally.
Details
News Market Reaction – LLY
The recorded move for LLY in the trading session of this news was +2.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast will be available on the "Webcasts & Presentations" section of
About
Refer to: | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-guggenheim-oncology-conference-301737770.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
